We are live on ! Find out more
CEI

Clark Estates Inc Portfolio holdings

AUM $434M
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+15%
3 Year Est. Return
+34.46%
5 Year Est. Return
+32.78%
10 Year Est. Return
+216.75%
AUM
$434M
AUM Growth
+$17.5M
Cap. Flow
-$3.16M
Cap. Flow %
-0.73%
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18
Avg Time Held
10.2 quarters
Top 10 Avg Time Held
4.1 quarters
Top 20 Avg Time Held
5.7 quarters

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$25.8M
2
HSIC icon
Henry Schein
HSIC
+$9.71M
3
UL icon
Unilever
UL
+$3.76M
4
BBY icon
Best Buy
BBY
+$2.9M
5
SONY icon
Sony
SONY
+$2.81M

Top Sells

Rank Stock Value
1
ECML icon
Euclidean Fundamental Value ETF
ECML
+$15M
2
AVNS icon
Avanos Medical
AVNS
+$11.8M
3
IQV icon
IQVIA
IQV
+$7.5M
4
SOLV icon
Solventum
SOLV
+$6.56M
5
MDT icon
Medtronic
MDT
+$5.24M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Miscellaneous 21.8%
3 Technology 13.51%
4 Communication Services 11.78%
5 Consumer Staples 7.78%

No holdings matched the selected filter criteria.

Similar funds

Clark Estates Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Clark Estates Inc held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clark Estates Inc's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.

  • Clark Estates Inc's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
  • Clark Estates Inc added most to Henry Schein in Q2 2026, an estimated $9.71M increase.
  • Clark Estates Inc's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
  • Clark Estates Inc fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
  • Clark Estates Inc's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
  • Clark Estates Inc opened 11 new positions and closed 18 in Q2 2026.
  • Clark Estates Inc's portfolio value rose 4.2% quarter-over-quarter to $434M.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.